HAL (France)open access
Synergistic SGLT2 and GLP-1R targeting alleviates systemic inflammation-induced and M1 monocyte-driven endothelial dysfunction in coronary artery disease
Inflammation, SGLT2 Inhibitors, Coronary Artery Disease, 1, Monocyte-Endothelial Crosstalk, 0, GLP-1R Agonists, 2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 468257
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.